Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia

Authors

  • Pasquale Niscola Hematology Unit, S. Eugenio Hospital, Rome, Italy
  • Benedetta Neri Hematology Unit, S. Eugenio Hospital, Rome, Italy
  • Gianfranco Catalano Hematology Unit, S. Eugenio Hospital, Rome, Italy
  • Luciana Morino Hematology Unit, S. Eugenio Hospital, Rome, Italy
  • Marco Giovannini Hematology Unit, S. Eugenio Hospital, Rome, Italy
  • Laura Scaramucci Hematology Unit, S. Eugenio Hospital, Rome, Italy
  • Stefano Fratoni Pathology Unit, S. Eugenio Hospital, Rome, Italy
  • Nélida Inés Noguera Neuro Oncohematology Unit, Santa Lucia Foundation, Rome, Italy
  • Iole Cordone Clinical Pathology, Regina Elena National Cancer Institute, Rome, Italy
  • Paolo de Fabritiis Hematology Unit, S. Eugenio Hospital, Rome, Italy

DOI:

https://doi.org/10.1080/0284186X.2017.1287947

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2017-08-03

How to Cite

Niscola, P., Neri, B., Catalano, G., Morino, L., Giovannini, M., Scaramucci, L., … de Fabritiis, P. (2017). Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. Acta Oncologica, 56(8), 1120–1121. https://doi.org/10.1080/0284186X.2017.1287947

Issue

Vol. 56 No. 8 (2017): Acta Oncologica

Section

Articles